Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P SmallCap Health Care ETF

54.70
-0.1760-0.32%
Volume:1K
Turnover:73.98K
Market Cap:184.35M
PE:- -
High:54.70
Open:54.70
Low:54.70
Close:54.88
52wk High:56.45
52wk Low:39.08
Shares:3.37M
Float Shares:3.37M
Volume Ratio:0.27
T/O Rate:0.04%
Dividend:0.00
Dividend Rate:0.01%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Krystal Biotech to Speak at Cantor Global Healthcare Conference Fireside Chat

Reuters
·
3 hours ago

Clean Sweep or Split Congress, These are the Trades to Make on the Midterms Outcome, Says JPMorgan

Dow Jones
·
4 hours ago

Molina Healthcare Updates Financial Calendar with Third-Quarter Earnings Release, Conference Call

Reuters
·
Yesterday

Alkermes EVP R&D, Chief Medical Officer Craig C. Hopkinson Disposes of 9,000 Shares for $422,874

Reuters
·
Yesterday

Affordable Housing Stocks Investors Are Watching As Social Spending Moves Center Stage

Simply Wall St.
·
Sep 01

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

TIPRANKS
·
Aug 31

Corcept Therapeutics Insider Makes Major Multimillion-Dollar Stock Move

TIPRANKS
·
Aug 29

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

TIPRANKS
·
Aug 29

Takeda receives FDA approval of NDA for Mimrylo

TIPRANKS
·
Aug 29

Corcept Endocrinology President Sean Maduck Disposes of 30,955 Corcept Shares Worth $3.88 Million

Reuters
·
Aug 28

Brightspring Health Services Inc Stock (BTSG) Closed Up by 7.20% on Aug 26: Key Drivers Unveiled

TradingKey
·
Aug 27

Roche receives FDA approval for companion diagnostic tests for Ziihera

TIPRANKS
·
Aug 27

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

TIPRANKS
·
Aug 27

Revolution Medicines announces FDA approval of Rasonque in adults

TIPRANKS
·
Aug 27

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25

Alkermes’ Alixorexton Posts Positive Phase 2 Vibrance-1 Results in Narcolepsy Type 1 Study

Reuters
·
Aug 25

The Lancet Neurology Publishes Data from Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults with Narcolepsy Type 1

THOMSON REUTERS
·
Aug 25

Krystal Biotech (KRYS) Rallies On Pipeline Hopes But Is The Valuation Already Priced In

Simply Wall St.
·
Aug 23

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

Corcept Therapeutics Director David L. Mahoney Sells 103,606 Shares Worth $12.26 Million

Reuters
·
Aug 21